Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Jaguar Health (JAGX) Land & Improvements (2017 - 2018)

Jaguar Health (JAGX) has disclosed Land & Improvements for 2 consecutive years, with $396247.0 as the latest value for Q1 2018.

Quarterly Land & Improvements changed N/A to $396247.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $396247.0 through Mar 2018, changed N/A year-over-year, with the annual reading at $396247.0 for FY2017, N/A changed from the prior year.
Land & Improvements for Q1 2018 was $396247.0 at Jaguar Health, roughly flat from $396247.0 in the prior quarter.
The five-year high for Land & Improvements was $396247.0 in Q4 2017, with the low at $396247.0 in Q4 2017.